BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6886282)

  • 21. The effects of ergoloid mesylates and ginkgo biloba on the pharmacokinetics of ticlopidine.
    Lu WJ; Huang JD; Lai ML
    J Clin Pharmacol; 2006 Jun; 46(6):628-34. PubMed ID: 16707409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydergine treatment and psychophysiological measures in primary degenerative dementia.
    Kuskowski MA; Morley G; Malone SM; Dysken MW; Okaya A
    J Geriatr Psychiatry Neurol; 1990; 3(1):41-7. PubMed ID: 2189430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapy comparison between the combination hydergine/nifedipine and nifedipine alone in patients with isolated systolic hypertension].
    Dominiak P; Weidinger G
    Med Klin (Munich); 1991 Jan; 86(1):15-9. PubMed ID: 2017111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A study of 93 cases of painful shoulder and shoulder-band syndrome treated with hydergine (author's transl)].
    Yaya Huamán R; Blasco Olcina R; García Fernández M; Vilches Padilla JJ
    Rev Esp Otoneurooftalmol Neurocir; 1975; 33(193):131-5. PubMed ID: 56021
    [No Abstract]   [Full Text] [Related]  

  • 26. [ELECTROCARDIOGRAMS IN NEUROVEGETATIVE DYSTONIA IN AGED SUBJECTS AND DIFFERENTIAL DIAGNOSTIC VALUE OF THE HYDERGINE TEST].
    NECCHIDELLASILVA A
    G Gerontol; 1964 Feb; 12():251-5. PubMed ID: 14163042
    [No Abstract]   [Full Text] [Related]  

  • 27. On the hypertensive action of tolazoline and hydergine.
    BENFEY BG; VARMA DR
    Can J Biochem Physiol; 1963 Apr; 41():941-6. PubMed ID: 13967428
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
    Rosenberg G; Angel I; Kozak A
    Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine.
    Loew DM; Jaton AL; Vigouret JM
    Postgrad Med J; 1976; 52suppl 1():40-46. PubMed ID: 822407
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of an antihypertensive drug during psychological stress. A double-blind study].
    Rösler F; Wegener H; Eulenberger D; Dahme B
    Arzneimittelforschung; 1975 Jun; 25(6):965-72. PubMed ID: 809046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia.
    Thienhaus OJ; Wheeler BG; Simon S; Zemlan FP; Hartford JT
    J Am Geriatr Soc; 1987 Mar; 35(3):219-23. PubMed ID: 3819261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of oral hydergine (ergoloid mesylates) in alcohol related encephalopathy.
    Datta KD; Evenson RC; Gannon PJ; Dick EP
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(1):87-90. PubMed ID: 3299496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
    Hughes JR; Williams JG; Currier RD
    J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ergoloid mesylates vs. Alzheimer's: the latest round.
    Walker C
    Geriatrics; 1990 Dec; 45(12):22, 24. PubMed ID: 2253892
    [No Abstract]   [Full Text] [Related]  

  • 35. [Iskedyl and general anesthesia. Measurement of the systolic ejection volume and peripheral resistance using the arterial pressure curves].
    Laborit G; Seroussi S; Neff R
    Ann Anesthesiol Fr; 1975; 16(2):69-76. PubMed ID: 5007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2001; (2):CD000359. PubMed ID: 11405961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the rat electrocorticogram following administration of two dihydrogenated ergot derivatives.
    Carruthers-Jones DI; Depoortere H; Loew DM
    Gerontology; 1978; 24 Suppl 1():23-33. PubMed ID: 412729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of dihydroergotoxin and phentolamine on the alpha--adrenoreceptors of the vessels of the kidney and intestines].
    Buianov VV
    Farmakol Toksikol; 1974; 37(6):674-6. PubMed ID: 4219191
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydergine-thioridazine combination in the treatment of psychopathological states in old age.
    Predescu V; Giurezu T; Tudorache D; Nica S; Ionescu R; Nicolschi L; Nitrurad A; Popvici E; Curelaru S
    Act Nerv Super (Praha); 1974 Aug; 16(3):237-8. PubMed ID: 4214302
    [No Abstract]   [Full Text] [Related]  

  • 40. [CLINICAL EVLUATION OF HYDERGINE IN GERIATRIC THERAPY].
    SOPRANA M; FRANZONI A
    Minerva Med; 1965 Jun; 56():2220-6. PubMed ID: 14341447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.